HSD13 Factors Associated with Prescribing of Teriflunomide and Dimethyl Fumarate Versus Fingolimod in Multiple Sclerosis

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1015
https://www.valueinhealthjournal.com/article/S1098-3015(22)01216-5/fulltext
Title : HSD13 Factors Associated with Prescribing of Teriflunomide and Dimethyl Fumarate Versus Fingolimod in Multiple Sclerosis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01216-5&doi=10.1016/j.jval.2022.04.1015
First page :
Section Title :
Open access? : No
Section Order : 10917
Categories :
Tags :
Regions :
ViH Article Tags :